{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cell stress", "HSF1", "Nrf2", "hepatotoxic", "viability"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26789234", "DateCompleted": {"Year": "2017", "Month": "02", "Day": "13"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "01", "Day": "20"}], "ELocationID": ["10.3109/13880209.2015.1107104"], "Language": ["eng"], "Journal": {"ISSN": "1744-5116", "JournalIssue": {"Volume": "54", "Issue": "9", "PubDate": {"Year": "2016", "Month": "Sep"}}, "Title": "Pharmaceutical biology", "ISOAbbreviation": "Pharm Biol"}, "ArticleTitle": "Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes.", "Pagination": {"StartPage": "1503", "EndPage": "1512", "MedlinePgn": "1503-12"}, "Abstract": {"AbstractText": ["Context Flavokawains are secondary metabolites from the kava plant (Piper methysticum Forst. f., Piperaceae) that have anticancer properties and demonstrated oral efficacy in murine cancer models. However, flavokawains also have suspected roles in rare cases of kava-induced hepatotoxicity. Objective To compare the toxicity flavokawains A and B (FKA, FKB) and monitor the resulting transcriptional responses and cellular adaptation in the human hepatocyte cell line, HepG2. Materials and methods HepG2 were treated with 2-100\u2009\u03bcM FKA or FKB for 24-48\u2009h. Cellular viability was measured with calcein-AM and changes in signalling and gene expression were monitored by luciferase reporter assay, real-time PCR and Western blot of both total and nuclear protein extracts. To test for subsequent resistance to oxidative stress, cells were pretreated with 50\u2009\u03bcM FKA, 10\u2009\u03bcM FKB or 10\u2009\u03bcM sulphoraphane (SFN) for 24\u2009h, followed by 0.4-2.8\u2009mM H2O2 for 48\u2009h, and then viability was assessed. Results FKA (\u2264100\u2009\u03bcM) was not toxic to HepG2, whereas FKB caused significant cell death (IC50=23.2\u2009\u00b1\u20090.8\u2009\u03bcM). Both flavokawains activated Nrf2, increasing HMOX1 and GCLC expression and enhancing total glutathione levels over 2-fold (p\u2009<\u20090.05). FKA and FKB also activated HSF1, increasing HSPA1A and DNAJA4 expression. Also, flavokawain pretreatment mitigated cell death after a subsequent challenge with H2O2, with FKA being more effective than FKB, and similar to SFN. Conclusions Flavokawains promote an adaptive cellular response that protects hepatocytes against oxidative stress. We propose that FKA has potential as a chemopreventative or chemotherapeutic agent."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Pharmaceutical Sciences , Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo , Hilo , HI , USA ;"}], "LastName": "Pinner", "ForeName": "Keanu D", "Initials": "KD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Pharmaceutical Sciences , Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo , Hilo , HI , USA ;"}], "LastName": "Wales", "ForeName": "Christina T K", "Initials": "CT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Pharmaceutical Sciences , Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo , Hilo , HI , USA ;"}], "LastName": "Gristock", "ForeName": "Rachel A", "Initials": "RA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Pharmaceutical Sciences , Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo , Hilo , HI , USA ;"}], "LastName": "Vo", "ForeName": "Hoa T", "Initials": "HT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Pharmaceutical Sciences , Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo , Hilo , HI , USA ;"}], "LastName": "So", "ForeName": "Nadine", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Pharmaceutical Sciences , Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo , Hilo , HI , USA ;"}, {"Identifier": [], "Affiliation": "b Cancer Biology Program, University of Hawaii Cancer Center , Honolulu , HI , USA."}], "LastName": "Jacobs", "ForeName": "Aaron T", "Initials": "AT"}], "GrantList": [{"GrantID": "P20 GM103466", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Pharm Biol", "NlmUniqueID": "9812552", "ISSNLinking": "1388-0209"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "DNAJA4 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "HSP40 Heat-Shock Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "HSP70 Heat-Shock Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "HSPA1A protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-E2-Related Factor 2"}, {"RegistryNumber": "0", "NameOfSubstance": "NFE2L2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "flavokawain A"}, {"RegistryNumber": "0", "NameOfSubstance": "flavokawain B"}, {"RegistryNumber": "5S5A2Q39HX", "NameOfSubstance": "Chalcone"}, {"RegistryNumber": "BBX060AN9V", "NameOfSubstance": "Hydrogen Peroxide"}, {"RegistryNumber": "EC 1.14.14.18", "NameOfSubstance": "HMOX1 protein, human"}, {"RegistryNumber": "EC 1.14.14.18", "NameOfSubstance": "Heme Oxygenase-1"}, {"RegistryNumber": "EC 6.3.2.2", "NameOfSubstance": "GCLC protein, human"}, {"RegistryNumber": "EC 6.3.2.2", "NameOfSubstance": "Glutamate-Cysteine Ligase"}, {"RegistryNumber": "GAN16C9B8O", "NameOfSubstance": "Glutathione"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "pharmacology", "toxicity"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["analogs & derivatives", "isolation & purification", "pharmacology", "toxicity"], "DescriptorName": "Chalcone"}, {"QualifierName": [], "DescriptorName": "Cytoprotection"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["isolation & purification", "pharmacology", "toxicity"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Glutamate-Cysteine Ligase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glutathione"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "HSP40 Heat-Shock Proteins"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "HSP70 Heat-Shock Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Heat-Shock Response"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Heme Oxygenase-1"}, {"QualifierName": [], "DescriptorName": "Hep G2 Cells"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Hepatocytes"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["toxicity"], "DescriptorName": "Hydrogen Peroxide"}, {"QualifierName": ["chemistry"], "DescriptorName": "Kava"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "NF-E2-Related Factor 2"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology", "toxicity"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": [], "DescriptorName": "Up-Regulation"}], "CoiStatement": "statement: Keanu Pinner is the son of Dean Pinner, owner of Pinner Creek Organics in Hilo, HI. All other authors of this work have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abu N, Ho WY, Yeap SK, et al. The flavokawains: Uprising medicinal chalcones. Cancer Cell Int. 2013;13:102.", "ArticleIdList": ["PMC4015927", "24148263"]}, {"Citation": "Abu N, Akhtar MN, Yeap SK, et al. Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro. PLoS One. 2014;9:e105244.", "ArticleIdList": ["PMC4186755", "25286005"]}, {"Citation": "Abu N, Mohamed NE, Yeap SK, et al. In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice. Drug Des Devel Ther. 2015;9:1401\u201317.", "ArticleIdList": ["PMC4358690", "25834398"]}, {"Citation": "An J, Gao Y, Wang J, et al. Flavokawain B induces apoptosis of non-small cell lung cancer H460 cells via Bax-initiated mitochondrial and JNK pathway. Biotechnol Lett. 2012;34:1781\u20138.", "ArticleIdList": ["22729748"]}, {"Citation": "Anckar J, Sistonen L. Regulation of HSF1 function in the heat stress response: Implications in aging and disease. Annu Rev Biochem. 2011;80:1089\u2013115.", "ArticleIdList": ["21417720"]}, {"Citation": "Baird L, Dinkova-Kostova AT. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol. 2011;85:241\u201372.", "ArticleIdList": ["21365312"]}, {"Citation": "Chen HC, Guh JY, Tsai JH, et al. Induction of heat shock protein 70 protects mesangial cells against oxidative injury. Kidney Int. 1999;56:1270\u20133.", "ArticleIdList": ["10504472"]}, {"Citation": "Chiu HY, Tsao LY, Yang RC. Heat-shock response protects peripheral blood mononuclear cells (PBMCs) from hydrogen peroxide-induced mitochondrial disturbance. Cell Stress Chaperones. 2009;14:207\u201317.", "ArticleIdList": ["PMC2727987", "18763057"]}, {"Citation": "Clarke JD, Dashwood RH, Ho E. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 2008;269:291\u2013304.", "ArticleIdList": ["PMC2579766", "18504070"]}, {"Citation": "Connor RE, Marnett LJ, Liebler DC. Protein-selective capture to analyze electrophile adduction of hsp90 by 4-hydroxynonenal. Chem Res Toxicol. 2011;24:1275\u201382.", "ArticleIdList": ["PMC3155980", "21749116"]}, {"Citation": "Currie BJ, Clough AR. Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use? Med J Aust. 2003;178:421\u20132.", "ArticleIdList": ["12720503"]}, {"Citation": "Dharmaratne HR, Nanayakkara NP, Khan IA. Kavalactones from Piper methysticum, and their 13C NMR spectroscopic analyses. Phytochemistry. 2002;59:429\u201333.", "ArticleIdList": ["11830162"]}, {"Citation": "Folmer F, Blasius R, Morceau F, et al. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Biochem Pharmacol. 2006;71:1206\u201318.", "ArticleIdList": ["16464438"]}, {"Citation": "Forman HJ, Dickinson DA. Oxidative signaling and glutathione synthesis. Biofactors. 2003;17:1\u201312.", "ArticleIdList": ["12897423"]}, {"Citation": "Geier FP, Konstantinowicz T. Kava treatment in patients with anxiety. Phytother Res. 2004;18:297\u2013300.", "ArticleIdList": ["15162364"]}, {"Citation": "Gleitz J, Friese J, Beile A, et al. Anticonvulsive action of (+/\u2212)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites. Eur J Pharmacol. 1996;315:89\u201397.", "ArticleIdList": ["8960869"]}, {"Citation": "Gounder R. Kava consumption and its health effects. Pac Health Dialog. 2006;13:131\u20135.", "ArticleIdList": ["18181402"]}, {"Citation": "Hseu YC, Lee MS, Wu CR, et al. The chalcone flavokawain B induces G2/M cell-cycle arrest and apoptosis in human oral carcinoma HSC-3 cells through the intracellular ROS generation and downregulation of the Akt/p38 MAPK signaling pathway. J Agric Food Chem. 2012;60:2385\u201397.", "ArticleIdList": ["22324429"]}, {"Citation": "Itoh K, Wakabayashi N, Katoh Y, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13:76\u201386.", "ArticleIdList": ["PMC316370", "9887101"]}, {"Citation": "Jacobs AT, Marnett LJ. Systems analysis of protein modification and cellular responses induced by electrophile stress. Acc Chem Res. 2010;43:673\u201383.", "ArticleIdList": ["PMC2873822", "20218676"]}, {"Citation": "Jhoo JW, Freeman JP, Heinze TM, et al. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum) J Agric Food Chem. 2006;54:3157\u201362.", "ArticleIdList": ["16608246"]}, {"Citation": "Kalmar B, Greensmith L. Induction of heat shock proteins for protection against oxidative stress. Adv Drug Deliv Rev. 2009;61:310\u20138.", "ArticleIdList": ["19248813"]}, {"Citation": "Kerns M, DePianto D, Yamamoto M, et al. Differential modulation of keratin expression by sulforaphane occurs via Nrf2-dependent and -independent pathways in skin epithelia. Mol Biol Cell. 2010;21:4068\u201375.", "ArticleIdList": ["PMC2993737", "20926689"]}, {"Citation": "Kim BR, Hu R, Keum YS, et al. Effects of glutathione on antioxidant response element-mediated gene expression and apoptosis elicited by sulforaphane. Cancer Res. 2003;63:7520\u20135.", "ArticleIdList": ["14612554"]}, {"Citation": "Kwon DJ, Ju SM, Youn GS, et al. Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-kappaB and AP-1 activation in RAW 264.7 macrophages. Food Chem Toxicol. 2013;58:479\u201386.", "ArticleIdList": ["23727179"]}, {"Citation": "Lebot V, Lindstrom L, Merlin M. Kava: The Pacific Drug. New Haven, CT: Yale University Press; 1992."}, {"Citation": "Lenzi M, Fimognari C, Hrelia P. Sulforaphane as a promising molecule for fighting cancer. Cancer Treat Res. 2014;159:207\u201323.", "ArticleIdList": ["24114482"]}, {"Citation": "Li N, Liu JH, Zhang J, et al. Comparative evaluation of cytotoxicity and antioxidative activity of 20 flavonoids. J Agric Food Chem. 2008;56:3876\u201383.", "ArticleIdList": ["18433100"]}, {"Citation": "Li XZ, Ramzan I. Role of ethanol in kava hepatotoxicity. Phytother Res. 2010;24:475\u201380.", "ArticleIdList": ["19943335"]}, {"Citation": "Li Z, Srivastava P. Heat-shock proteins. Curr Protoc Immunol. 2004 Appendix 1: Appendix 1T.", "ArticleIdList": ["18432918"]}, {"Citation": "Liu Z, Xu X, Li X, et al. Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model. Cancer Prev Res (Phila) 2013;6:1365\u201375.", "ArticleIdList": ["PMC3873822", "24121102"]}, {"Citation": "Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830:3143\u201353.", "ArticleIdList": ["PMC3549305", "22995213"]}, {"Citation": "Ma Q, He X. Molecular basis of electrophilic and oxidative defense: Promises and perils of Nrf2. Pharmacol Rev. 2012;64:1055\u201381.", "ArticleIdList": ["PMC4648289", "22966037"]}, {"Citation": "Martin AC, Johnston E, Xing C, et al. Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster) PLoS One. 2014;9:e111572.", "ArticleIdList": ["PMC4218769", "25365244"]}, {"Citation": "McMahon M, Itoh K, Yamamoto M, et al. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem. 2003;278:21592\u2013600.", "ArticleIdList": ["12682069"]}, {"Citation": "Narayanapillai SC, Leitzman P, O\u2019Sullivan MG, et al. Flavokawains a and B in kava, not dihydromethysticin, potentiate acetaminophen-induced hepatotoxicity in C57BL/6 mice. Chem Res Toxicol. 2014;27:1871\u20136.", "ArticleIdList": ["PMC4203398", "25185080"]}, {"Citation": "Olsen LR, Grillo MP, Skonberg C. Constituents in kava extracts potentially involved in hepatotoxicity: A review. Chem Res Toxicol. 2011;24:992\u20131002.", "ArticleIdList": ["21506562"]}, {"Citation": "Qiu XB, Shao YM, Miao S, et al. The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cell Mol Life Sci. 2006;63:2560\u201370.", "ArticleIdList": ["PMC11136209", "16952052"]}, {"Citation": "Samarasinghe B, Wales CT, Taylor FR, et al. Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux. Biochem Pharmacol. 2014;87:445\u201355.", "ArticleIdList": ["PMC3934577", "24291777"]}, {"Citation": "Sarris J, Stough C, Bousman CA, et al. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol. 2013;33:643\u20138.", "ArticleIdList": ["23635869"]}, {"Citation": "Sedlak TW, Saleh M, Higginson DS, et al. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci U S A. 2009;106:5171\u20136.", "ArticleIdList": ["PMC2664041", "19286972"]}, {"Citation": "Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal. 2004;6:841\u20139.", "ArticleIdList": ["15345144"]}, {"Citation": "Tang Y, Simoneau AR, Xie J, et al. Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53. Cancer Prev Res (Phila) 2008;1:439\u201351.", "ArticleIdList": ["PMC2830727", "19138991"]}, {"Citation": "Tang Y, Li X, Liu Z, et al. Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth. Int J Cancer. 2010;127:1758\u201368.", "ArticleIdList": ["PMC2888737", "20112340"]}, {"Citation": "Teschke R, Genthner A, Wolff A. Kava hepatotoxicity: Comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures. J Ethnopharmacol. 2009;123:378\u201384.", "ArticleIdList": ["19501269"]}, {"Citation": "Teschke R. Kava hepatotoxicity: Pathogenetic aspects and prospective considerations. Liver Int. 2010a;30:1270\u20139.", "ArticleIdList": ["20630022"]}, {"Citation": "Teschke R. Kava hepatotoxicity. A clinical review. Ann Hepatol. 2010b;9:251\u201365.", "ArticleIdList": ["20720265"]}, {"Citation": "Teschke R, Qiu SX, Lebot V. Herbal hepatotoxicity by kava: Update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits. Dig Liver Dis. 2011;43:676\u201381.", "ArticleIdList": ["21377431"]}, {"Citation": "West JD, Marnett LJ. Alterations in gene expression induced by the lipid peroxidation product, 4-hydroxy-2-nonenal. Chem Res Toxicol. 2005;18:1642\u201353.", "ArticleIdList": ["16300372"]}, {"Citation": "Zi X, Simoneau AR. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res. 2005;65:3479\u201386.", "ArticleIdList": ["15833884"]}, {"Citation": "Zou J, Guo Y, Guettouche T, et al. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell. 1998;94:471\u201380.", "ArticleIdList": ["9727490"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "1", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "1", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26789234", "NIHMS817893", "PMC5040346", "10.3109/13880209.2015.1107104"]}}], "PubmedBookArticle": []}